Related Experiment Video
Updated: Jan 16, 2026

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
Published on: January 30, 2017
Co-Detection of ADV, Influenza B, and HPIV: Independent Risk Factors for SMPP with Changes in NPIs
1Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou 215000, China.
Abstract:
Background: This study investigated the epidemiology of Mycoplasma pneumoniae (MP) in children with acute respiratory tract infections (ARTIs) and explored the risk factors for severe mycoplasma pneumoniae pneumonia (SMPP) in children. Methods: A retrospective analysis was conducted on 36,380 children with acute respiratory infections who underwent multiplex real-time polymerase chain reaction (RT-PCR) assays for nine respiratory pathogens from September 2021 to November 2024. Results: A total of 36,380 children with ARTIs were enrolled in this study. The co-detection rate of MP with other pathogens was significantly higher in the post-NPIs period than in the NPIs period (36.5% vs. 25.7%, p < 0.01). Multivariate regression identified the detection of influenza A virus (InfA), InfB, human parainfluenza virus (HPIV), human bocaparvovirus (HBoV), human rhinovirus (HRV), adenovirus (ADV), human respiratory syncytial virus (HRSV), and human metapneumovirus (HMPV) as protective factors against MP epidemics (p < 0.01); meanwhile, older age, the cancellation of NPIs, and summer-autumn seasons were found to be risk factors. After adjusting for sex, age, period, season, and pathogens, InfB (OR: 3.009, 95%CI: 1.041-8.697, p = 0.042), HPIV (OR: 2.226, 95%CI: 1.170-4.235, p = 0.015), and ADV (OR: 2.035, 95%CI: 1.105-3.750, p = 0.023) were identified as independent risk factors for SMPP. Conclusions: These findings highlight post-NPI shifts in MP epidemiology and identify ADV, InfB, and HPIV as early warning markers for SMPP.
Insights
Mycoplasma pneumoniae (MP) epidemiology shifted post-NPIs, with higher co-detection rates. Adenovirus (ADV), influenza B virus (InfB), and human parainfluenza virus (HPIV) are key risk factors for severe MP pneumonia in children.
Area of Science:
- Pediatric Infectious Diseases
- Respiratory Virology
- Epidemiology
Background:
- Investigated Mycoplasma pneumoniae (MP) epidemiology in children with acute respiratory tract infections (ARTIs).
- Explored risk factors associated with severe Mycoplasma pneumoniae pneumonia (SMPP) in pediatric populations.
- Examined shifts in MP epidemiology following the implementation and lifting of non-pharmaceutical interventions (NPIs).
Purpose of the Study:
- To analyze the epidemiological trends of MP in children experiencing ARTIs.
- To identify independent risk factors contributing to the development of severe MP pneumonia (SMPP).
- To assess the impact of NPIs on MP co-detection rates and epidemic patterns.
Main Methods:
- Retrospective analysis of 36,380 children with ARTIs from September 2021 to November 2024.
- Utilized multiplex real-time polymerase chain reaction (RT-PCR) for detecting nine common respiratory pathogens.
- Employed multivariate regression analysis to determine risk and protective factors for MP epidemics and SMPP.
Main Results:
- MP co-detection rates were significantly higher in the post-NPI period (36.5%) compared to the NPI period (25.7%).
- Influenza A virus, InfB, HPIV, HBoV, HRV, ADV, HRSV, and HMPV were protective against MP epidemics.
- Independent risk factors for SMPP included InfB, HPIV, and ADV, with increased odds ratios observed.
Conclusions:
- Post-NPIs have led to significant shifts in MP epidemiology among children with ARTIs.
- Adenovirus (ADV), influenza B virus (InfB), and human parainfluenza virus (HPIV) serve as crucial early warning markers for severe MP pneumonia (SMPP).
- Understanding these epidemiological changes and risk factors is vital for managing pediatric respiratory infections.
More Related Videos
Related Concept Videos
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Leaky Scanning
Single Nucleotide Polymorphisms-SNPs

